These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 6184557

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Sensitivity to Ca2+ and the effects of a calcium channel antagonist in resistance vessels from two strains of genetically hypertensive rat.
    Cassie NJ, Cross MA, Phelan EL, Millar JA.
    J Cardiovasc Pharmacol; 1990; 16 Suppl 7():S12-3. PubMed ID: 1708010
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Vascular smooth muscle calcium channels.
    van Breemen C, Cauvin C, Yamamoto H, Zschauer A.
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S10-6. PubMed ID: 2455103
    [Abstract] [Full Text] [Related]

  • 26. Mechanisms of action of calcium antagonists in hypertension.
    Kiowski W, Bolli P, Erne P, Hulthén UL, Bühler FR.
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S23-8. PubMed ID: 2455134
    [Abstract] [Full Text] [Related]

  • 27. Arterial resistance vessels in primary hypertension--evidence for altered cellular Ca2+ metabolism.
    Zidek W, Heckmann U, Vischer P, Gruenwald J, Kerenyi T.
    J Cardiovasc Pharmacol; 1987; 10 Suppl 6():S91-6. PubMed ID: 2485035
    [Abstract] [Full Text] [Related]

  • 28. Calcium antagonists and excitation of the vascular muscle membrane.
    Hermsmeyer K, Kuthe C.
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S933-6. PubMed ID: 6085380
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Elevation of spontaneous tone and effects of antihypertensive treatments in arterial smooth muscle of spontaneously hypertensive rats].
    Sunano S, Sasaki F.
    J Smooth Muscle Res; 1993 Aug; 29(4):111-30. PubMed ID: 8136558
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Anomalies in smooth muscle fibers and arterial hypertension].
    Mulvany MJ.
    Nephrologie; 1989 Aug; 10(2):51-4. PubMed ID: 2677814
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Calcium kinetics and effects of calcium antagonist on vascular smooth muscle].
    Aoki K, Miyagawa K.
    Nihon Rinsho; 1989 Aug; 47(8):1746-52. PubMed ID: 2585737
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Clinical effects of calcium antagonists in hypertensive diabetics.
    Marre M, Fressinaud P.
    J Cardiovasc Pharmacol; 1990 Aug; 16 Suppl 2():S13-5. PubMed ID: 1369702
    [Abstract] [Full Text] [Related]

  • 39. Calcium entry blocking activities of MPC-1304 and of its enantiomers and metabolites.
    Okumura K, Ichihara K, Nagasaka M, Oda N, Tajima K.
    Eur J Pharmacol; 1993 Apr 22; 235(1):69-74. PubMed ID: 8519282
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.